Zydus Life USFDA inspection at Ahmedabad plant concludes with 1 observation

Zydus Lifesciences said on Monday, September 28, a US Food and Drug Administration (USFDA) inspection at its manufacturing facility at SEZ II, Ahmedabad, has concluded with one observation.The current Good Manufacturing Practices (cGMP) inspection was conducted from September 21 to September 28, 20…